Michel Tod Handling Concentrations Below Quantification Limit in Population
|
Sandrine MICALLEF, Thomas J. SMITH, Frédéric Y. BOIS Modelling of intra-individual and inter-individual variability in 1,3-butadiene metabolism
|
Liping Zhang Simultaneous vs. Sequential Estimation in PK/PD Data Analysis
|
S. Gisbert, I. Gueorguieva, G. Graham, L. Aarons Incorporating Uncertainty and Variability in the Physiological Parameters of a PBPK Model
|
I. Gueorguieva, I. Nestorov, M. Rowland Reducing PBPK Models Using Global Sensitivity Analysis and Benefit/Cost Criterion
|
Chanu Pascal, Tranchand Brigitte, Robert Jacques Population pharmacokinetics of epirubicin and its main metabolite epirubicinol using NONMEM
|
Georges B., Saivin S., Archambaud M., Conil JM., Decun JF., Cougot P., Virenque C., Houin G. Cefepime Monitoring in ICU Patients Using a Population Pharmacokinetic Approach
|
Kim Emil Andersen and Malene Højbjerre A Bayesian Approach to Bergman's Minimal Model
|
Ulrika Wählby(1), Alison H. Thomson(2), Peter A. Milligan(3) and Mats O. Karlsson(1) Handling of time-varying covariates in population model building.
|
Susanne Bøttcher and Claus Dethlefsen Bayesian Networks used in PK/PD modelling
|
Rizo-Manika M, Saivin S, Georges B, Conil JM, Lavit M, Houin G Validation Of An Amikacin Population Pharmacokinetics Model To Be Used In Intensive Care Unit
|
Jian-Feng Lu and René Bruno Assessment of the Predictive Performance of a New Population Pharmacokinetic Model For Trastuzumab (Herceptin) and Simulation of Trastuzumab Steady-State Exposure During Long-Term Weekly Dosing.
|
Andreas V. Groth, Mikael S. Thomsen, Morten Colding-Jørgensen & Erik Mosekilde Discussion of criteria for evaluating the quality of glucose clamp studies
|
M.J. García1, D. Santos Buelga1,D. Aumente2, P. Gomez2 ,JC.Lukas1 Population pharmacokinetics of long-term methotrexate in children with lymphoblastic leukemia
|
D. Santos Buelga1, M.J. García1, MJ Otero2, A. Martin Suarez1, A. Dominguez-Gil2, JC.Lukas1 Phenytoin covariate models for Michaelis-Menten pharmacokinetics in adult epileptic patients
|
C. Csajka(1), C. Marzolini(1), K. Fattinger(2), L.A. Décosterd(1), J. Fellay(3), A. Telenti(3), J. Biollaz(1), T. Buclin(1) Population Pharmacokinetics and Effects of Efavirenz in HIV Patients
|
Jakob Ribbing and E. Niclas Jonsson The Effect of Collinearity on the Selection of Covariates in Population Pharmacokinetic Analysis
|
Hussain Mulla, Fazal Nabi, Sanjiv Nichani, Richard K Firmin, Graham Lawson, David R Upton Population Pharmacokinetics of Theophylline during Paediatric Extracorporeal Membrane Oxygenation (ECMO)
|
Valle M, Riba J, Yritia M, Barbanoj MJ. Pharmacokinetics of the three main alkaloids present in the South American psychoactive beverage Ayahuasca after oral administration to healthy volunteers
|
Siv Jönsson and Mats O. Karlsson Estimating Bias In Parameters For Some NONMEM Models For Ordered Categorical Data
|
Juan Jose Perez Ruixo(1); Vladimir Piotrovsky(1); Kenneth H. Cowan(2); Louis Weiner (3); Cornelis J.A. Punt (4); Martine Piccart (5). Population Pharmacokinetic Analysis of Zarnestra Using Data From Phase I Clinical Trials
|
J.B. Fau * & C. Dubruc *, F. Mentré **. Population PK/PD modelling of a new MAO-B inhibitor in young and elderly healthy volunteers.
|
Eric Masson, 1, Eliane Fuseau, 2, Valérie Cosson, 2 Efficiency of Using Population Pharmacokinetics to Demonstrate Bioequivalence with Sparse Sampling in Cancer Patients- A Trial Simulation with Etoposide
|
Vermeulen, An and Piotrovsky, Vladimir Modelling of the effect of carbamazepine on the pharmacokinetics of risperidone in psychotic patients of different phenotypes
|
Merle Y.(1), Treluyer JM* (2), Tonnelier S (2), Rey E (2), Pons G (2). Nonparametric Population Analysis Of Amikacin Pharmacokinetic Data In A Pediatric Population.
|
L.Claret(1), P.Macheras(2), N.Simon(3), A.Iliadis(4) The Use Of A Stochastic Model For Data Exhibiting Heterogeneous Pharmacokinetics
|
L. Nguyen (1), S. Retout (2), F. Mentré (2), P. Variol (1) and C. Puozzo (1) Population pharmacokinetics of vinflunine from phase I data and evaluation of population sampling designs for further clinical development
|
Xuejun Chen, Suresh Mallikaarjun, Zhao Wang, Steven L. Bramer Population PK Modeling of drugs exhibiting less than proportional increases in pharmacokinetics relative to increasing doses
|
A.A. Yao(a), J.T. Slattery(b,c), G.B. McDonald(c), and P. Vicini(a) Population pharmacokinetics of cyclophosphamide and its metabolites in hematopoietic stem-cell transplantation patients
|
P.Baille-Albert (1), O.Petricoul (1), E.Fuseau (1), A.Iliadis (2) Information indexes for exploratory data analysis in population pharmacokinetics
|
Sophie Glatt1, Olivier Petricoul1, Ciara Rossier2, Quyen T.X Nguyen2, Alain Munafo2, Timothy Goggin2, Mauro Buraglio2, and Eliane Fuseau1 Pooled PK analysis of Interferon-beta-1a (Rebif), data obtained in healthy subjects and in patients.
|
Lars Lindbom, Mats O. Karlsson, E. Niclas Jonsson Symmetry and coverage of confidence intervals for a population PK model.
|
Ziad Hussein (1), Maria Pitsiu (1), Oneeb Majid (1), L. Aarons (2), A. Stockis (3) and M. de Longueville (3) Retrospective Population Pharmacokinetics Of Cetirizine In Infants And Children
|
Xiaofeng Wang and Siu-Kei Tin Population pharmacokinetics model validation using Kinetica
|
Perdaems Lambert N.(1), Bouzom F.(1), Freidig A.(2), Solbes Marchetti M.N.(1), Jochemsen R.(3), and Walther B.(1) The Use Of Physiologically Based Pharmacokinetic (PBPK) Model In Drug Development
|
L. Del Frari, F. Bouzom, B. Walther and R.Jochemsen Pharmacokinetic Mixed Effects Modelling of S16257 After Oral Administration in the Beagle Dog; Combined Analysis
|
A. Diot(1,2), C. Laveille(2), N. Frey(2), R. Jochemsen(2) & A. Mallet(1) Gauss Hermite Quadrature in Population Parameters Estimation. Application to the Detection of Subpopulations
|
Howard Lee, Hui C. Kimko, Mark Rogge, Diane Wang, Ivan Nestorov and Carl C. Peck Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis
|
F.Hourcade-Potelleret *, C. Laveille *, M.Tod ** and R. Jochemsen * Mixture models : simulation and estimation with NONMEM
|
D. Martin , N. Frey , C. Laveille , H. Merdjan and R. Jochemsen Pharmacokinetic mixed effects modelling of a new compound in rat - Combined analysis.
|
In-Sun Nam, Leon Aarons The propagation of information in PK modelling: The use of IV information to support the analysis of PK data
|
G.Würthwein1, T.Klingebiel2, S.Krümpelmann3, M.Metz4, K.Schwenker4, C.Lanvers1, J. Boos1 Population pharmacokinetics of high-dose etoposide in children receiving different conditioning regimens
|